Martin J. Wygod, Chairman and Acting Chief Executive Officer of HLTH
Corporation, said: "WebMD, HLTH's 84% owned subsidiary, continues to
demonstrate its strength as the leading source of health information for
consumers and health care professionals. WebMD's third quarter advertising
sales, which we believe is an early indicator for 2009 growth, suggests our
customers are looking to more aggressively integrate online strategies into
their core marketing mix to both consumer and healthcare professionals in
2009."

Consolidated Financial Highlights

Revenue for the third quarter was $100.4 million, an increase of 17%
over the prior year. Earnings before interest, taxes, non-cash and other
items ("Adjusted EBITDA") for the third quarter was $22.5 million, an
increase of 23% over the prior year. Income from continuing operations for
the third quarter was $2.6 million or $0.01 per share. Income from
discontinued operations was $93.2 million or $0.50 per share and net income
was $95.9 million or $0.51 per share.

At September 30, 2008, HLTH had approximately $1.66 billion in cash and
investments, of which $332.6 million is attributable to WebMD.

Segment Operating Results

Online Services segment revenue was $94.6 million for the third quarter
compared to $79.6 million in the prior year period, an increase of 19%.
Advertising and sponsorship revenue increased 22%, from the prior year
period, to $72.0 million. Private portal licensing revenue increased 11%,
from the prior year period, to $22.1 million. Online Services segment
Adjusted EBITDA increased 18% to $26.0 million compared to $21.9 million in
the prior year period.

Traffic to the WebMD Health Network continued to grow strongly with an
average of 49.9 million unique users per month and total traffic of 1.14
billion page views during the third quarter, increases of 22% and 33%,
respectively, from a year ago. In the third quarter, 1.3 million continuing
medical education (CME) programs were completed on the WebMD Professional
Network, an increase of 76% from the prior year period.

The base of large employers and health plans utilizing WebMD's private
Health and Benefits portals during the third quarter was 129 as compared to
112 a year ago. During the quarter, WebMD significantly expanded its
relationship with Wal-Mart Stores, Inc. and added Tyco International
Management Company, Viacom, Inc., Presbyterian Health Plan, Inc. and Golden
Living to its customer base.

Publishing and Other Services segment revenue was $5.8 million for the
third quarter compared to $6.5 million in the prior year period, a decrease
of 11% primarily related to weakness in the Company's Little Blue Book
print product for physicians. Publishing and Other Services segment
Adjusted EBITDA was $1.2 million compared to $2.1 million in the prior year
period.

Discontinued Operations

HLTH's financial results present the ViPS and Porex businesses as
discontinued operations in the current and prior year periods, reflecting
the sale of ViPS and the decision to divest Porex. The sale of the ViPS
business was completed on July 22, 2008 for $225 million in cash, which
resulted in a gain of approximately $92 million, net of income taxes during
the current quarter. WebMD's offline professional medical reference and
textbook publication business is presented as a discontinued operation in
the prior year period, reflecting the sale of that business on December 31,
2007.

Financial Guidance

WebMD provided financial guidance for the three months ending December
31, 2008 and for the year ending December 31, 2009 in a separate press
release issued by WebMD and in a Form 8-K filed by WebMD today. HLTH is not
providing consolidated financial guidance at this time.

Analyst and Investor Conference Call

As previously announced, HLTH and WebMD will host a conference call at
4:45 pm (Eastern) today to discuss their respective third quarter results.
Investors can access the call via webcast at http://www.hlth.com (in the Investor
Relations section). A replay of the call will be available at the same web
address.

About HLTH

HLTH Corporation (Nasdaq: HLTH) owns approximately 84% of WebMD Health
Corp. (Nasdaq: WBMD). WebMD is the leading provider of health information
services, serving consumers, physicians, healthcare professionals,
employers and health plans through its public and private online portals
and health-focused publications. HLTH also owns Porex, a developer,
manufacturer and distributor of proprietary porous plastic products and
components used in healthcare, industrial and consumer applications.

All statements contained in this press release and the related analyst
and investor conference call, other than statements of historical fact, are
forward-looking statements, including those regarding: our guidance on
HLTH's and WebMD's future financial results and other projections or
measures of their future performance; market opportunities and WebMD's
ability to capitalize on them; the benefits expected from new products or
services and from other potential sources of additional revenue;
expectations regarding the market for WebMD's and HLTH's investments in
auction rate securities (ARS); and the potential sale transaction with
respect to Porex (the "Potential Porex Transaction"). These statements
speak only as of the date of this press release, are based on HLTH's and
WebMD's current plans and expectations, and involve risks and uncertainties
that could cause actual future events or results to be different than those
described in or implied by such forward-looking statements. These risks and
uncertainties include those relating to: market acceptance of WebMD's
products and services; WebMD's relationships with customers and strategic
partners; changes in the markets for ARS; and changes in economic,
political or regulatory conditions or other trends affecting the
healthcare, Internet, information technology and plastics industries.
Further information about these matters can be found in our other
Securities and Exchange Commission filings. In addition, there can be no
assurances regarding whether HLTH will be able to complete the Potential
Porex Transaction or as to the timing or terms of such transaction. Except
as required by applicable law or regulation, we do not undertake any
obligation to update our forward-looking statements to reflect future
events or circumstances.

This press release, and the accompanying tables, include both financial
measures in accordance with accounting principles generally accepted in the
United States of America, or GAAP, as well as certain non-GAAP financial
measures. The tables attached to this press release include reconciliations
of these non-GAAP financial measures to GAAP financial measures. In
addition, an "Explanation of Non-GAAP Financial Measures" is attached to
this press release as Annex A.

WebMD(R), WebMD Health(R) and POREX(R) are trademarks of HLTH
Corporation or its subsidiaries.

-Tables Follow-

HLTH CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data, unaudited)

Three Months Nine Months

Ended Ended

September 30, September 30,

2008 2007 2008 2007

Revenue $100,367 $86,034 $271,185 $235,112

Costs and expenses:

Cost of operations 35,323 30,021 99,656 87,636

Sales and marketing 26,439 22,459 77,729 67,258

General and administrative 22,929 25,718 67,254 81,111

Depreciation and amortization 7,265 7,390 21,468 20,954

Interest income 9,386 10,864 29,384 30,638

Interest expense 4,636 4,660 13,871 13,985

Gain on sale of EBS Master LLC - - 538,024 -

Impairment of auction rate

securities - - 60,108 -

Other (expense) income, net (997) 989 (5,807) 5,267

Income from continuing

operations before income

tax provision 12,164 7,639 492,700 73

Income tax provision 7,679 2,977 34,623 4,404

Minority interest in WHC

income (loss) 1,845 1,800 (929) 2,758

Equity in earnings of EBS

Master LLC - 8,005 4,007 22,679

Income from continuing

operations 2,640 10,867 463,013 15,590

Income (loss) from discontinued

operations, net of tax 93,241 5,704 93,159 (38,780)

Net income (loss) $95,881 $16,571 $556,172 $(23,190)

Basic income (loss) per common

share:

Income from continuing operations $0.01 $0.06 $2.53 $0.09

Income (loss) from discontinued

operations 0.51 0.03 0.51 (0.22)

Net income (loss) $0.52 $0.09 $3.04 $(0.13)

Diluted income (loss) per

common share:

Income from continuing operations $0.01 $0.06 $2.06 $0.08

Income (loss) from discontinued

operations 0.50 0.03 0.41 (0.21)

Net income (loss) $0.51 $0.09 $2.47 $(0.13)

Weighted-average shares

outstanding used in

computing income (loss) per

common share:

Basic 183,716 179,811 182,838 178,681

Diluted 187,527 188,071 228,653 188,486

HLTH CORPORATION

CONSOLIDATED SEGMENT INFORMATION

(In thousands, except per share data, unaudited)

Three Months Nine Months

Ended Ended

September 30, September 30,

2008 2007 2008 2007

Revenue

WebMD Online Services:

Advertising and sponsorship $72,046 $59,087 $190,494 $158,944

Licensing 22,139 20,001 65,928 59,915

Content syndication and

other 392 490 1,154 2,027

Total WebMD Online Services 94,577 79,578 257,576 220,886

WebMD Publishing and Other

Services 5,810 6,520 13,669 14,426

Inter-segment eliminations (20) (64) (60) (200)

$100,367 $86,034 $271,185 $235,112

Earnings before interest, taxes,

non-cash and other items

("Adjusted EBITDA") (a)

WebMD Online Services $25,956 $21,948 $61,287 $48,982

WebMD Publishing and Other

Services 1,212 2,138 1,485 2,643

Corporate (4,679) (5,811) (15,311) (18,874)

$22,489 $18,275 $47,461 $32,751

Adjusted EBITDA per diluted

common share (b) $0.12 $0.10 $0.21 $0.17

Interest, taxes,

non-cash and other

items (c)

Interest income $9,386 $10,864 $29,384 $30,638

Interest expense (4,636) (4,660) (13,871) (13,985)

Income tax provision (7,679) (2,977) (34,623) (4,404)

Depreciation and

amortization (7,265) (7,390) (21,468) (20,954)

Non-cash stock-based

compensation (6,531) (9,285) (18,974) (26,246)

Non-cash advertising (178) (169) (1,736) (2,489)

Minority interest in WHC

(income) loss (1,845) (1,800) 929 (2,758)

Equity in earnings of EBS

Master LLC - 8,005 4,007 22,679

Gain on sale of EBS

Master LLC - - 538,024 -

Impairment of auction rate

securities - - (60,108) -

Other (expense) income, net (1,101) 4 (6,012) 358

Income from

continuing operations 2,640 10,867 463,013 15,590

Income (loss) from

discontinued operations,

net of tax 93,241 5,704 93,159 (38,780)

Net income (loss) $95,881 $16,571 $556,172 $(23,190)

Basic income

(loss) per common

share:

Income from continuing

operations $0.01 $0.06 $2.53 $0.09

Income (loss) from

discontinued operations 0.51 0.03 0.51 (0.22)

Net income (loss) $0.52 $0.09 $3.04 $(0.13)

Diluted income

(loss) per common

share:

Income from continuing

operations $0.01 $0.06 $2.06 $0.08

Income (loss) from

discontinued operations 0.50 0.03 0.41 (0.21)

Net income (loss) $0.51 $0.09 $2.47 $(0.13)

Weighted-average

shares outstanding used

in computing income (loss) per

common share:

Basic 183,716 179,811 182,838 178,681

Diluted 187,527 188,071 228,653 188,486

(a) See Annex A -- Explanation of Non-GAAP Financial Measures.

(b) Adjusted EBITDA per diluted common share is based on the

weighted-average shares outstanding used in computing diluted income

(loss) per common share.

(c) Reconciliation of Adjusted EBITDA to income from continuing

operations.

HLTH CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, unaudited)

September 30, 2008 December 31, 2007

Assets

Cash and cash equivalents $1,380,179 $536,879

Short-term investments 284,789 290,858

Accounts receivable, net 78,148 86,081

Due from EBS Master LLC - 1,224

Prepaid expenses and other current

assets 27,190 71,090

Assets of discontinued operations 119,891 262,964

Total current assets 1,890,197 1,249,096

Marketable equity securities 2,175 2,383

Property and equipment, net 51,766 49,554

Goodwill 211,414 217,323

Intangible assets, net 28,917 36,314

Investment in EBS Master LLC - 25,261

Other assets 36,534 71,466

Total Assets $2,221,003 $1,651,397

Liabilities and Stockholders' Equity

Accrued expenses $44,305 $49,598

Deferred revenue 81,740 76,401

Liabilities of discontinued

operations 100,464 123,131

Total current liabilities 226,509 249,130

Convertible notes 650,000 650,000

Other long-term liabilities 21,184 21,137

Minority interest in WHC 139,250 131,353

Stockholders' equity 1,184,060 599,777

Total Liabilities and Stockholders'

Equity $2,221,003 $1,651,397

HLTH CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands, unaudited)

Nine Months Ended

September 30,

2008 2007

Cash flows from operating activities:

Net income (loss) $556,172 $(23,190)

Adjustments to reconcile net income (loss)

to net cash provided by operating

activities:

(Income) loss from discontinued

operations, net of tax (93,159) 38,780

Depreciation and amortization 21,468 20,954

Minority interest in WHC (loss) income (929) 2,758

Equity in earnings of EBS Master LLC (4,007) (22,679)

Amortization of debt issuance costs 2,248 2,179

Non-cash advertising 1,736 2,489

Non-cash stock-based compensation 18,974 26,246

Deferred income taxes 11,934 3,710

Gain on sale of EBS Master LLC and 2006

EBS Sale (538,024) (399)

Impairment of auction rate securities 60,108 -

Changes in operating assets and

liabilities:

Accounts receivable 7,932 14,835

Prepaid expenses and other, net 4,174 (198)

Accrued expenses and other

long-term liabilities (3,639) (45,878)

Deferred revenue 5,340 3,253

Net cash provided by continuing

operations 50,328 22,860

Net cash provided by discontinued

operations 28,497 24,366

Net cash provided by operating

activities 78,825 47,226

Cash flows from investing activities:

Proceeds from maturities and sales of

available-for-sale securities 117,539 356,492

Purchases of available-for-sale securities (177,150) (694,522)

Purchases of property and equipment (15,115) (14,427)

Proceeds related to the sales of ViPS,

EBS, EPS and ACS/ACP, net of expenses 821,706 14,565

Decreases in net advances to EBS Master LLC 1,224 19,921

Other 148 -

Net cash provided by (used in)

continuing operations 748,352 (317,971)

Net cash used in discontinued

operations (4,265) (3,785)

Net cash provided by (used in)

investing activities 744,087 (321,756)

Cash flows from financing activities:

Proceeds from issuance of HLTH and WHC

common stock 20,725 114,077

Purchases of treasury stock under

repurchase program - (47,120)

Other 343 (18)

Net cash provided by continuing

operations 21,068 66,939

Net cash used in discontinued

operations (76) (130)

Net cash provided by financing

activities 20,992 66,809

Effect of exchange rates on cash (604) 1,042

Net increase (decrease) in cash and cash

equivalents 843,300 (206,679)

Cash and cash equivalents at beginning of

period 536,879 614,691

Cash and cash equivalents at end of period $1,380,179 $408,012

ANNEX A

Explanation of Non-GAAP Financial Measures

The accompanying HLTH Corporation press release and financial tables
include both financial measures in accordance with U.S. generally accepted
accounting principles, or GAAP, as well as non-GAAP financial measures. The
non-GAAP financial measures represent earnings before interest, taxes,
non-cash and other items (which we refer to as "Adjusted EBITDA") and
related per share amounts. Adjusted EBITDA should be viewed as supplemental
to, and not as an alternative for, "income (loss) from continuing
operations" or "net income (loss)" calculated in accordance with GAAP. The
tables attached to the accompanying press release include reconciliations
of non-GAAP financial measures to GAAP financial measures.

Adjusted EBITDA is used by HLTH's management as an additional measure
of HLTH's overall performance and its reporting segments' performance for
purposes of business decision-making, including developing budgets,
managing expenditures, and evaluating potential acquisitions or
divestitures. Period-to-period comparisons of Adjusted EBITDA help HLTH's
management identify additional trends in HLTH's and its reporting segments'
financial results that may not be shown solely by period-to-period
comparisons of income (loss) from continuing operations or net income
(loss). In addition, HLTH uses Adjusted EBITDA in the incentive
compensation programs applicable to many of its employees in order to
evaluate HLTH's performance. HLTH management recognizes that Adjusted
EBITDA has inherent limitations because of the excluded items, particularly
those items that are recurring in nature. In order to compensate for those
limitations, management also reviews the specific items that are excluded
from Adjusted EBITDA, but included in income (loss) from continuing
operations or net income (loss), as well as trends in those items. The
amounts of those items are set forth, for the applicable periods, in the
reconciliations of Adjusted EBITDA to income (loss) from continuing
operations or to net income (loss) that accompany our press releases
containing non-GAAP financial measures, including the reconciliations
contained in the tables attached to the accompanying press release.

HLTH believes that the presentation of Adjusted EBITDA is useful to
investors in their analysis of HLTH's results for reasons similar to the
reasons why HLTH's management finds it useful and because it helps
facilitate investor understanding of decisions made by HLTH's management in
light of the performance metrics used in making those decisions. In
addition, as more fully described below, HLTH believes that providing
Adjusted EBITDA, together with a reconciliation of Adjusted EBITDA to
income (loss) from continuing operations or to net income (loss), helps
investors make comparisons between HLTH and other companies that may have
different capital structures, different effective income tax rates and tax
attributes, different capitalized asset values and/or different forms of
employee compensation. However, Adjusted EBITDA is intended to provide a
supplemental way of comparing HLTH with other public companies and is not
intended as a substitute for comparisons based on "income (loss) from
continuing operations" or "net income (loss)" calculated in accordance with
GAAP. In making any comparisons to other companies, investors need to be
aware that companies use different non-GAAP measures to evaluate their
financial performance. Investors should pay close attention to the specific
definition being used and to the reconciliation between such measures and
the corresponding GAAP measures provided by each company under applicable
SEC rules.

The following is an explanation of the items excluded by HLTH from
Adjusted EBITDA but included in income (loss) from continuing operations in
the accompanying press release:

-- Depreciation and Amortization. Depreciation and amortization expense is

a non-cash expense relating to capital expenditures and intangible

assets arising from acquisitions that are expensed on a straight-line

basis over the estimated useful life of the related assets. HLTH

excludes depreciation and amortization expense from Adjusted EBITDA

because it believes (i) the amount of such expenses in any specific

period may not directly correlate to the underlying performance of

HLTH's business operations and (ii) such expenses can vary

significantly between periods as a result of new acquisitions and full

amortization of previously acquired tangible and intangible assets.

Accordingly, HLTH believes this exclusion assists management and

investors in making period-to-period comparisons of operating

performance. Investors should note that the use of tangible and

intangible assets contributed to revenue in the periods presented and

will contribute to future revenue generation and should also note that

(Date:12/8/2016)... ... 2016 , ... After enjoying record-breaking attendance at its last ... 33rd Annual Issues & Research Conference, March 2-3, 2017, at the Westin ... is “Persistent Challenges and New Opportunities: Using Research to Accelerate the Dialogue." 2016 ...

(Date:12/8/2016)... ... ... CURE Media Group, the nation’s leading digital and print media enterprise focused on ... efforts to combat lung cancer, announced CURE Media Group President Michael J. Hennessy, Jr. ... honored to team up with Upstage Lung Cancer in order to make major strides ...

(Date:12/8/2016)... Peachtree City, Ga (PRWEB) , ... December 08, ... ... and moving as soon after surgery as possible. With this in mind, SIGVARIS ... vein thrombosis (DVT or blood clot) during bed rest and provide the benefits ...

(Date:12/8/2016)... ... December 08, 2016 , ... The ... offices headquartered in Jefferson County, is announcing the launch of a charity drive ... The number of homeless women and children in Birmingham has grown steadily since ...

(Date:12/8/2016)... 8, 2016 Diplomat Pharmacy, Inc. (NYSE: DPLO) has been recognized ... Top Workplaces National Standard. To learn more about ... ... Inc.) ... survey administered by WorkplaceDynamics, LLC, a research firm specializing in organizational ...

(Date:12/8/2016)... Research and Markets has announced the addition ... Adhesion Type, Application, Usability - Forecast to 2025" report to ... , , ... poised to grow at a CAGR of around 3.2% from 2015 ... witnessing include advancements in extracellular microelectrode arrays and intracellular microelectrodes, research ...

(Date:12/8/2016)... Dec. 8, 2016 Pennsylvania Physician General Dr. ... and Alcohol Programs Gary Tennis released ... known as benzodiazepines, developed with the help of ... medications that are frequently prescribed for anxiety or ... used with opioid pain medications, benzodiazepines pose a ...